Dermfree Original Nasal Spray
NDC Package 85248-112-01
Package Information
Dermfree Original Nasal (naphazoline hcl 0.05%original nasal) sprays is adults&children 12 years &older(with adult supervision ):2 or 3 sprays in each nostril,not more often than every 10 to 12 hours.Do not exceed 2 doses in 24 hours.Ask a doctor: children 6 to under 12 years.Do not use children under 6 years. This formulation utilizes a spray delivery system. Marketed by Jiangxi Yudexi Pharmaceutical Co., Ltd, this product is identified by NDC 85248-112 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1046610 - naphazoline HCl 0.05 % Nasal Spray
- RxCUI: 1046610 - naphazoline hydrochloride 0.5 MG/ML Nasal Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85248 - Jiangxi Yudexi Pharmaceutical Co., Ltd
- 85248-112 - Dermfree Original Nasal
- 85248-112-01 - 30 mL in 1 BOTTLE
- 85248-112 - Dermfree Original Nasal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85248-112-01 identifies a specific commercial package of 30 ml in 1 bottle of Dermfree Original Nasal, a human over the counter drug labeled by Jiangxi Yudexi Pharmaceutical Co., Ltd. This spray is formulated for nasal use and contains naphazoline hcl as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Jiangxi Yudexi Pharmaceutical Co., Ltd on February 08, 2026. The current certification is valid through December 31, 2027.
How is this Jiangxi Yudexi Pharmaceutical Co., Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85248011201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.